Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
D. E. Shaw & Co., L.P. reported a 5.10% stake in Agios Pharmaceuticals, Inc. (Schedule 13G)
Event Jun 25, 2026 · Filed Jul 2, 2026
D. E. Shaw & Co., L.P. reported a 5.10% stake in Agios Pharmaceuticals, Inc., 3,034,031 shares, as a passive investor on Jun 25, 2026. Filed Jul 2, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 3,034,031
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| D. E. Shaw & Co., L.P. | 5.10% | 3,034,031 |
| David E. Shaw | 5.10% | 3,034,031 |
Source
Related
- Agios Pharmaceuticals, Inc.
- D. E. Shaw & Co., L.P.
- Agios Pharmaceuticals, Inc. shareholders
- Form 4 · Gheuens Sarah · Aug 6, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 3, 2026
- Form 4 · Backstrom Jay T. · Jul 10, 2026
- Form 4 · Gheuens Sarah · Jul 2, 2026
- Form 4 · Ballal Rahul D. · Jun 23, 2026